心脏性休克:当代方法和持续挑战的回顾
Lea R Goren1, Xuan Ding1, Maeve Jones-O'Connor1
1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Future cardiology
|August 30, 2025
概括
心脏性休克 (CS) 的治疗非常复杂. 本综述涵盖了CS定义,病理生理学和基于证据的治疗方法,如重血管化和微轴流,突出了知识差距和正在进行的试验.
科学领域:
- 心脏病学
- 危急护理医学
背景情况:
- 心脏性休克 (CS) 是一种导致器官衰竭的心力输出不足的危急状态.
- 了解CS异质性和分类对于有效管理至关重要.
研究的目的:
- 审查心脏性休克的定义,病理生理学,分类和管理.
- 突出最近的进展和基于证据的治疗方法.
- 确定现有证据缺口和正在进行的CS管理试验.
主要方法:
- 专注于心脏性休克的文献审查.
- 对CS表型异质性和分类的最新进展进行分析.
- 基于证据的治疗干预措施和机械循环支持 (MCS) 设备的评估.
主要成果:
- 在特定的CS病例 (如STEMI) 中,新兴的再血管化和微轴流显示出生存益处.
- 对于其他医学疗法和MCS设备的证据仍然有限.
- 目前存在显著的证据缺口,正在进行的试验将为未来的临床实践提供信息.
结论:
- 有效的心脏冲击管理需要了解其复杂的病理生理学和异质性.
- 虽然基于证据的治疗方法有限,但在精选的CS群体中提供生存益处.
- 进一步的研究和正在进行的临床试验对于完善CS治疗策略至关重要.
相关概念视频
Cardiopulmonary Resuscitation IV: Pharmacological Management
75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
Blood Pressure Imbalances and Circulatory Shock
998
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
998
Cardiomyopathy V: Interprofessional Care
32
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Acute Coronary Syndrome IV: Interprofessional Care
26
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
26
Cardiomyopathy II: Dilated Cardiomyopathy
21
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Ischemic Heart Disease: Overview
1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K


